NASDAQ:MTBC - Medical Transcription Billing Stock Price, Price Target & More Sign in or create an account to add this stock to your watchlist. Get Started $4.80 +0.03 (+0.63 %) (As of 07/22/2018 08:14 AM ET)Previous Close$4.80Today's Range$4.62 - $4.8052-Week Range$1.16 - $5.44Volume207,359 shsAverage Volume330,866 shsMarket Capitalization$55.99 millionP/E Ratio-36.92Dividend YieldN/ABeta1.71 Company ProfileFinancialsAnalyst RatingsEarnings HistoryInsider TradesHeadlinesOptions ChainSEC FilingsSocial MediaChart Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Medical Transcription Billing, Corp. is a healthcare information technology company that provides an integrated suite of Web-based solutions, together with related business services, to healthcare providers practicing in ambulatory care settings. The Company's offering, PracticePro, allows healthcare practices with the core software and business services on Software-as-a-Service (SaaS) platform. PracticePro includes practice management software and related tools, which facilitate the day-to-day operation of a medical practice; electronic health records (EHR), which allow its customers to qualify for government incentives; revenue cycle management (RCM) services, which include medical billing, analytics and related services, and mobile Health (mHealth) solutions, including smartphone applications that assist patients and healthcare providers in the provision of healthcare services. The Company offers a clearinghouse service, which allows clients to track claim status. Receive MTBC News and Ratings via Email Sign-up to receive the latest news and ratings for MTBC and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Prepackaged software Sub-IndustryN/A SectorComputer and Technology SymbolNASDAQ:MTBC CUSIPN/A Webwww.mtbc.com Phone732-873-5133 Debt Debt-to-Equity RatioN/A Current Ratio2.36 Quick Ratio2.36 Price-To-Earnings Trailing P/E Ratio-36.92 Forward P/E Ratio-10.67 P/E GrowthN/A Sales & Book Value Annual Sales$31.81 million Price / Sales1.76 Cash Flow$0.2462 per share Price / Cash19.50 Book Value$1.76 per share Price / Book2.73 Profitability EPS (Most Recent Fiscal Year)($0.13) Net Income$-5,560,000.00 Net Margins-8.72% Return on Equity0.49% Return on Assets0.33% Miscellaneous Employees1,700 Outstanding Shares11,660,000Market Cap$55.99 Medical Transcription Billing (NASDAQ:MTBC) Frequently Asked Questions What is Medical Transcription Billing's stock symbol? Medical Transcription Billing trades on the NASDAQ under the ticker symbol "MTBC." How were Medical Transcription Billing's earnings last quarter? Medical Transcription Billing Corp (NASDAQ:MTBC) issued its quarterly earnings results on Tuesday, May, 15th. The technology company reported $0.05 earnings per share for the quarter, topping the consensus estimate of ($0.09) by $0.14. The technology company had revenue of $8.31 million for the quarter, compared to the consensus estimate of $7.98 million. Medical Transcription Billing had a positive return on equity of 0.49% and a negative net margin of 8.72%. View Medical Transcription Billing's Earnings History. When is Medical Transcription Billing's next earnings date? Medical Transcription Billing is scheduled to release their next quarterly earnings announcement on Wednesday, August, 8th 2018. View Earnings Estimates for Medical Transcription Billing. What price target have analysts set for MTBC? 3 Wall Street analysts have issued 1-year price targets for Medical Transcription Billing's stock. Their forecasts range from $2.75 to $6.00. On average, they anticipate Medical Transcription Billing's stock price to reach $4.3750 in the next year. This suggests that the stock has a possible downside of 8.9%. View Analyst Ratings for Medical Transcription Billing. What is the consensus analysts' recommendation for Medical Transcription Billing? 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medical Transcription Billing in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." What are Wall Street analysts saying about Medical Transcription Billing stock? Here are some recent quotes from research analysts about Medical Transcription Billing stock: 1. HC Wainwright analysts commented, "Financials; Expansion Opportunities Abound; Reit Buy Stock Data 03/07/2018 Price $3.53 Exchange NASDAQ Price Target $5.00 52-Week High $5.44 52-Week Low $0.29 Enterprise Value (M) $65 Market Cap (M) $41 Shares Outstanding (M) 11.5 3 Month Avg Volume 443,753 Short Interest (M) 1.00 Balance Sheet Metrics Cash (M) $4.4 Total Debt (M) $0.3 Total Cash/Share $0.38 General: EV includes 1.116M preferred shares at $25.89/shr. 3/7/18 for $28.9M in capitalization." (3/8/2018) 2. According to Zacks Investment Research, "Medical Transcription Billing, Corp. is a healthcare information technology company. It engages in providing integrated suite of proprietary web-based solutions, together with related business services, to healthcare providers practicing in ambulatory care settings. The Company offers revenue cycle, practice management services, patient scheduling, automated appointment reminders, e-prescribing, lab connectivity, and real-time insurance eligibility verification. Transcription Billing, Corp. is headquartered in Somerset, New Jersey. " (1/6/2018) Who are some of Medical Transcription Billing's key competitors? Some companies that are related to Medical Transcription Billing include Avid Technology (AVID), CLPS (CLPS), Datawatch (DWCH), Gridsum (GSUM), Cyren (CYRN), Inspired Entertainment (INSE), ImageWare Systems, Inc. common stock (IWSY), Link Motion (LKM), MAM Software Group (MAMS), Symbility Solutions (ATBEF), Rand Worldwide (RWWI), SharpSpring (SHSP), Aware (AWRE), Great Elm Capital Group (GEC) and Red Violet (RDVT). Has Medical Transcription Billing been receiving favorable news coverage? Headlines about MTBC stock have been trending somewhat positive this week, Accern Sentiment Analysis reports. Accern ranks the sentiment of media coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Medical Transcription Billing earned a news sentiment score of 0.13 on Accern's scale. They also assigned news articles about the technology company an impact score of 44.93 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company's share price in the near future. How do I buy shares of Medical Transcription Billing? Shares of MTBC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Medical Transcription Billing's stock price today? One share of MTBC stock can currently be purchased for approximately $4.80. How big of a company is Medical Transcription Billing? Medical Transcription Billing has a market capitalization of $55.99 million and generates $31.81 million in revenue each year. The technology company earns $-5,560,000.00 in net income (profit) each year or ($0.13) on an earnings per share basis. Medical Transcription Billing employs 1,700 workers across the globe. How can I contact Medical Transcription Billing? Medical Transcription Billing's mailing address is 7 CLYDE ROAD, SOMERSET NJ, 08873. The technology company can be reached via phone at 732-873-5133. MarketBeat Community Rating for Medical Transcription Billing (NASDAQ MTBC)Community Ranking: 2.2 out of 5 ( )Outperform Votes: 129 (Vote Outperform)Underperform Votes: 159 (Vote Underperform)Total Votes: 288MarketBeat's community ratings are surveys of what our community members think about Medical Transcription Billing and other stocks. Vote "Outperform" if you believe MTBC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MTBC will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 7/22/2018 by MarketBeat.com StaffFeatured Article: What is a closed-end mutual fund (CEF)?